Expand Access/Assess Safety and Efficacy of Paromomycin IM Injection for the Treatment of Visceral Leishmaniasis
NCT00604955
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
2000
Enrollment
OTHER
Sponsor class
Conditions
Visceral Leishmaniasis
Interventions
DRUG:
Paromomycin sulfate
Sponsor
PATH